Company record
Similasan AG
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Similasan AG.
Warning letters
-
DrugsSimilasan AG
Similasan AG's ophthalmic drugs are unapproved new drugs and violate CGMP (manufacturing quality rules), FDA says.
High risk